Purpose: To identify early features of Fuchs endothelial dystrophy (FED) in carriers of the rs613872(G) transcription factor 4 gene (TCF4) aged 20 to 21 years.
Results: Association between the rs613872 risk allele and corneal endothelial cell density (CD) as well as the coefficient of variation in cell shape was the main outcome measure. Genotype and specular microscopic data were available for a total of 445 participants (46% women). The median CD was 2851 and 2850 cells per square millimeter in the right and left eyes, respectively. No significant differences between intereye variability in endothelial CD were seen (right eye to left eye correlation = 0.64); however, a significant difference in variability of endothelial CD between men and women was observed (male: OD, 2839 6 124 cells/mm 2 and OS, 2845 6 124 cells/mm 2 vs. female: OD, 2838 6 134 cells/mm 2 and OS, 2842 6 132 cells/mm 2 ; OD, P = 0.0013 and OS, P = 0.0016). Eleven individuals were homozygous for the rs613872 risk allele. We found no association between rs613872 genotype and CD or coefficient of variation. One of 11 homozygous GG individuals was found to have a gutta in 1 sample field on specular microscopy, whereas 2 of 297 TT individuals also had a gutta each in 1 sample field.
Conclusions:
We were unable to detect an association between TCF4 rs613872 genotype and the variation in corneal endothelial CD or variation in cell morphology in a healthy young adult population.
Key Words: Fuchs endothelial dystrophy, genetics of corneal endothelium, birth cohort study, genome-wide association study (Cornea 2012; 31:162-166) F uchs endothelial dystrophy (FED) is a leading indication for corneal transplants in individuals living in developed countries. 1 FED is a slowly progressive, bilateral, but asymmetric, posterior corneal dystrophy clinically evident in the fifth and sixth decades of life 2,3 and later causes endothelial decompensation, resulting in visual impairment. 4 The first sign of FED is the presence of guttae on the Descemet membrane. 5 The relationship between corneal endothelial cell count and the variability of cell size (polymegathism) with FED is inconsistent in the literature. 6, 7 FED is a complex heterogeneous disease affecting approximately 38% of first-degree relatives of patients. 8 However, previous work suggests that there is a little difference in corneal endothelial cell count between first-degree relatives of individuals with FED. 9 Approximately 70% of the Fuchs original cohort was female, and more recently, it was found that women were 2.5 times more likely than men to be affected. 8, 10, 11 Early-onset disease has been associated with mutations in the COL8A2 gene located on chromosome 1p, presumably reflecting that the a2 subunit of collagen 8 is a component of the Descemet layer. 12 A genome-wide association study (GWAS) is a relatively new means of investigation and has been successful in identifying single-nucleotide polymorphisms (SNPs) associated with macular degeneration, pseudoexfoliation, myopia, and glaucoma (among others). GWAS holds great promise, particularly in the case of common complex diseases, because no previous information about underlying molecular mechanisms is required. In contrast to a candidate gene study, where typically only 1 particular gene locus is interrogated, in a GWAS, several hundred thousand SNPs dispersed across the genome are simultaneously investigated for association with a disease. Mutations identified in KCNJ13 on chromosome 2q, SLC4A11 on chromosome 20p, and ZEB1 on chromosome 10p have also been associated with rare forms of FED. [13] [14] [15] [16] Linkage of FED to chromosomes 5q, 9p, 13p, and 18q has been described. [16] [17] [18] [19] Recently, a GWAS identified an SNP in the transcription factor 4 gene (TCF4) (which encodes E2-2, a member of the E protein family) as being strongly associated with FED. 20 Individuals with 2 copies of the high-risk allele were almost 30 times more likely to develop FED. 20 A further study of 170 late-onset FED cases and 180 age-matched controls of Northern European descent interrogated 9 SNPs spanning the TCF4 locus and identified the rs61872 G risk allele as being significantly associated with late-onset FED (P = 4.28 3 10 215 , odds ratio = 4.2). 21 In this study, we sought to specifically investigate the role of the TCF4 gene in the normal variation in corneal endothelium in a population-based cohort of 20-to 21-year-old adults.
PARTICIPANTS AND METHODS
The Western Australian Pregnancy Cohort (Raine) Study was established in Perth in 1989 when an unselected cohort of 2900 pregnant women was recruited at 16 to 18 weeks' gestation from the King Edward Memorial Hospital and surrounding practices. It is one of the largest ongoing prospective cohorts of pregnancy, childhood, adolescence, and young adulthood. 22 The primary purpose of the Raine cohort was to investigate how events during pregnancy and at the time of birth subsequently influence health. Participants in the Raine study are currently being recruited and assessed as part of their 20-to 21-year follow-up, which includes each participant having specular microscopic measurements as part of a broad ophthalmic phenotyping. This is the first time that a comprehensive ophthalmic examination has been included as part of the Raine study follow-up. A total of 522 individuals took part in a pilot study for the Raine Eye Health Study (REHS). The REHS will compare ophthalmic diseases, traits, and biometry with previously assembled GWAS and environmental data of the cohort. The REHS was conducted in accordance with the tenets of the Declaration of Helsinki, and the protocol was approved by the Institutional Review Board at the University of Western Australia. Informed consent was obtained from all participants at the initiation of the examination session.
Of the 522 individuals, 77 participants did not have genetic data available. A subset of 445 individuals was selected for analysis based on the following criteria: singleton birth and no siblings in the study, white ethnicity, DNA sample, no congenital abnormalities, and available phenotype and genotype data.
Ophthalmic measurements were obtained from a maximum of 873 eyes (17 eyes did not have adequate images) of 445 participants examined with noncontact specular microscopy (EM-3000; Tomey, Nagoya, Japan). For each eye, 15 serial photographs of central corneal endothelium were recorded by using the autoalignment and autoshot functions of the instrument. The best-quality image is automatically selected and analyzed by the preinstalled software of the instrument (Cell and Layer Analyser; Tomey). The following parameters were automatically determined using the fixed-frame counting method in an area set to 100 mm 2 : the number of analyzed cells, cell density (CD), average cell size, standard deviation (SD), coefficient of variation (CV), and minimum and maximum values for cell area. No cell border correction was made. Central corneal thickness (CCT) was measured with the Tomey specular microscopy along with the corneal endothelial cell counts. Grading was not conducted at the time of testing, and poor quality scans were later excluded and not repeated.
Study individual genotype data for rs613872 were extracted from the genome-wide Illumina 660 Quad Array. Briefly, the genotyping was performed on the Illumina BeadArray Reader at the Centre for Applied Genomics (Toronto, Ontario, Canada) using 250 ng of DNA. Both the left eye and the right eye measurements were analyzed separately. Cross-sectional analyses of the eye measures were performed using multivariate linear regression adjusting for gender and rs613872 genotype coded as AA, AC, or CC (ie, codominant genetic model). The platform we used coded for the other strand of DNA, the SNP that was genotyped as A/C on our GWAS is presented as such, where we have transliterated to the HapMap database, which used the other strand with T/G alleles. We have 100% concordance between our genotyped and imputed data for this SNP.
Age was investigated for association with each outcome but was not significant over this small age range and was excluded from analysis. CD was approximately normally distributed, but CV was right skewed, so a log transformation was performed before analysis. All analyses were performed using the statistical graphics software R version 2.7.1. 23 A post hoc power calculation was carried out in the Quanto software package 24 to investigate whether this study had adequate power to detect a genetic association. In this study, we had more than 80% power to detect b $57 cells per square millimeter for CD and b $0.05 for log(CV) under a log-additive genetic model for the SNP rs613872 at the a level of 0.05.
RESULTS
Of the 445 participants who were included in the analysis, 205 (46%) were women and 240 (54%) were men. The average age of the participants was 20.14 years (SD = 0.29).
The median CD and CVs were determined for right and left eyes ( Table 1 ). Regardless of the gender, the median CD was 2851 and 2850 cells per square millimeter in the right and the left eyes, respectively. There was no significant difference in CD between the left and the right eyes (correlation = 0.64). There was no significant difference in variability in endothelial cell size between the left and the right eyes (correlation = 0.43); however, a difference was observed between men and women with respect to variability in endothelial CD, which appeared to be because of a difference in SD rather than average size.
The minor allele frequency of rs613872 was 0.18 (number in each genotype category: AA = 297, AC = 137, and CC = 11). The SNP was in Hardy-Weinberg equilibrium (P = 0.42) and had 100% call rate. Association analysis between the CD and rs613872 genotype in the left and the right eyes is shown in Table 2 . Association analysis between the cell size variability and rs613872 genotype in the left and the right eyes is displayed in Table 3 . Table 2 presents the effect size and statistical significance of each risk genotype of rs613872 in comparison with the major homozygote (AA) for the genetic association analysis of both CD and CV.
In the HapMap, A is annotated by the other strand T and C as G. No significant association was detected between either CD or cell size variability and rs613872 genotype in this sample of 445 individuals. An analysis of the other endothelial cell counts available, including number of cells, average and SD of cell size, and minimum and maximum cell size, demonstrated no obvious associations with the rs613872 genotype, except for in the minimum cell size variable, which indicated an increased minimum cell size with more copies of the risk (C) allele.
Association analysis using an additive genetic model was conducted for each SNP within an 800 kb of chromosome 18 that spans the TCF4 gene and beyond from the imputed data. Figure 1 indicates that SNPs across the TCF4 region were not associated with CD and cell size variability in this sample after a Bonferonni adjustment for the multiple tests conducted (P , 7 3 10 25 ).
One of the homozygous carriers of the risk allele showed a single endothelial gutta in the measurement zone of the left eye. The participants had specular microscopy that was not graded at the time of examination, and follow-up of abnormal results was not possible. No other carrier had any abnormality detected. Two of the noncarriers had a single endothelial gutta each in their sample field.
Because FED is associated with corneal edema, we also compared CCT in the cohort. CCT measurements were available on 436 right eyes (236 men and 200 women) and 437 left eyes (238 men and 199 women). Mean (SD) for CCT measurement with total set genders combined were as follows: right, 534.7 (34.6) mm and left: 527.9 (34.7) mm; with genders separated: male right, 533.6 (35.8) mm; female right, 535.9 (33.3) mm; male left, 526.6 (36.5) mm; female left, 529.5 (32.4) mm. There was no significant difference between men and women; however, there was an unexplained difference between right and left eyes (P = 0.004).
DISCUSSION
Identification of the TCF4 locus has enabled detection of those at high risk for developing FED. Through following people who harbor FED causing TCF4 mutations closely, we hope to recognize early signs of the disease and to identify other potential risk factors that exacerbate progression in those at increased genetic risk.
This study reveals that guttae, one of the early signs of FED, were not common among those young adults carrying the high-risk alleles for the disease (1 in 22 eyes). The youngest affected individual with a COL8A2 mutation in other genetic studies of FED was presymptomatic in his/her third decade with 1 to 2 mm of grouped central corneal guttae. 12 In addition, there was no difference in the corneal endothelial CD or polymegathism when compared with the wild-type controls. Follow-up studies of at-risk individuals in cohorts of young adults, such as this, will be of value in understanding the onset of visual impairment from FED. The finding in this study of an increased variability of cell size (greater distribution) in women compared with men may explain the higher prevalence of FED in women. Further genetic investigation of endothelial cell counts with GWAS may identify a sex-limited gene associated with this and FED. The G allele of rs613872 was not previously found to be more prevalent in women with FED. 21 Although the G allele of rs613872 was associated with increased risk for FED, it was not associated with severity of the disease. 21 Limitations of this study include the relatively small number of individuals involved. It is hoped that we will be able to expand the study to a full 1500 individuals with available genetic data in the coming years. Only 1 specular microscopic reading was taken, and this was not graded at the time of participant assessment. Moreover, further corneal examination to confirm other pathology and other signs of FED was not conducted. In conclusion, identification of risk alleles in the TCF4 gene by Baratz et al 20 allows presymptomatic detection of individuals at higher risk of FED. We did not identify any significant abnormality in endothelial cell counts in homozygous carriers aged 20 to 21 years, and guttae were not common in high-risk individuals of this age (1 of 11 homozygous carriers compared with 2 of 297 noncarriers).
